Wave Life Sciences Ltd. - Ordinary Shares, no par value (WVE)

CUSIP: Y95308105

Q1 2019 13F Holders as of 31 Mar 2019

Type / Class
Equity / Ordinary Shares, no par value
Shares outstanding
182,917,028
Total 13F shares
29,400,279
Share change
+5,001,879
Total reported value
$1,142,135,791
Put/Call ratio
331%
Price per share
$38.85
Number of holders
109
Value change
+$191,634,667
Number of buys
82
Number of sells
26

Quarterly Holders Quick Answers

What is CUSIP Y95308105?
CUSIP Y95308105 identifies WVE - Wave Life Sciences Ltd. - Ordinary Shares, no par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Wave Life Sciences Ltd. - Ordinary Shares, no par value (WVE) as of Q1 2019

As of 31 Mar 2019, Wave Life Sciences Ltd. - Ordinary Shares, no par value (WVE) was held by 109 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 29,400,279 shares. The largest 10 holders included RA CAPITAL MANAGEMENT, LLC, JANUS HENDERSON GROUP PLC, Redmile Group, LLC, BlackRock Inc., PRICE T ROWE ASSOCIATES INC /MD/, BB BIOTECH AG, BOXER CAPITAL, LLC, Partner Fund Management, L.P., WELLINGTON MANAGEMENT GROUP LLP, and Point72 Asset Management, L.P.. This page lists 109 institutional shareholders reporting positions in this security for the Q1 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.